Search research articles
Contact Us
Filters
Showing results (61-70 of 127) with videos related to
Page
of 13
Sort By:
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
October 16, 2019
Zoledronic Acid Improves Muscle Function in Healthy Mice Treated with Chemotherapy
Brian A Hain, Baptiste Jude, Haifang Xu, et al.
International Journal of MS Care
|
February 27, 2016
Gastrointestinal Tolerability of Delayed-Release Dimethyl Fumarate in a Multicenter, Open-Label Study of Patients with Relapsing Forms of Multiple Sclerosis (MANAGE)
Edward J Fox, Alberto Vasquez, William Grainger, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
April 2, 2015
dNTP pool levels modulate mutator phenotypes of error-prone DNA polymerase ε variants
Lindsey N Williams, Lisette Marjavaara, Gary M Knowels, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
February 21, 2021
Survival after palliative radiation therapy for cancer: The METSSS model
Nicholas G Zaorsky, Menglu Liang, Rutu Patel, et al.
The Journal of Molecular Diagnostics : JMD
|
January 27, 2006
Mutually exclusive promoter hypermethylation patterns of hMLH1 and O6-methylguanine DNA methyltransferase in colorectal cancer
Edward J Fox, Dermot T Leahy, Robert Geraghty, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
June 24, 2014
Effects of CP-900691, a novel peroxisome proliferator-activated receptor α, agonist on diabetic nephropathy in the BTBR ob/ob mouse
Bardia Askari, Tomasz Wietecha, Kelly L Hudkins, et al.
Therapeutic Advances in Neurological Disorders
|
May 31, 2018
Phase IV study of retention on fingolimod <i>versus</i> injectable multiple sclerosis therapies: a randomized clinical trial
Bruce A C Cree, Douglas L Arnold, Mark Cascione, et al.
Nature Methods
|
April 8, 2015
Sequencing small genomic targets with high efficiency and extreme accuracy
Michael W Schmitt, Edward J Fox, Marc J Prindle, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
November 13, 2018
Ocrelizumab reduces progression of upper extremity impairment in patients with primary progressive multiple sclerosis: Findings from the phase III randomized ORATORIO trial
Edward J Fox, Clyde Markowitz, Angela Applebee, et al.
Biorxiv : the Preprint Server for Biology
|
July 15, 2025
Multiplex Proteomics of Lewy Body Dementia Reveals Cerebrospinal Fluid Biomarkers of Disease Pathology and Progression
Lenora Higginbotham, Anantharaman Shantaraman, Qi Guo, et al.
Page
of 13
Search research articles
Search
Showing results (61-70 of 127) with videos related to
Sort By:
Page
of 13
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
October 16, 2019
Zoledronic Acid Improves Muscle Function in Healthy Mice Treated with Chemotherapy
Brian A Hain, Baptiste Jude, Haifang Xu, et al.
International Journal of MS Care
|
February 27, 2016
Gastrointestinal Tolerability of Delayed-Release Dimethyl Fumarate in a Multicenter, Open-Label Study of Patients with Relapsing Forms of Multiple Sclerosis (MANAGE)
Edward J Fox, Alberto Vasquez, William Grainger, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
April 2, 2015
dNTP pool levels modulate mutator phenotypes of error-prone DNA polymerase ε variants
Lindsey N Williams, Lisette Marjavaara, Gary M Knowels, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
February 21, 2021
Survival after palliative radiation therapy for cancer: The METSSS model
Nicholas G Zaorsky, Menglu Liang, Rutu Patel, et al.
The Journal of Molecular Diagnostics : JMD
|
January 27, 2006
Mutually exclusive promoter hypermethylation patterns of hMLH1 and O6-methylguanine DNA methyltransferase in colorectal cancer
Edward J Fox, Dermot T Leahy, Robert Geraghty, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
June 24, 2014
Effects of CP-900691, a novel peroxisome proliferator-activated receptor α, agonist on diabetic nephropathy in the BTBR ob/ob mouse
Bardia Askari, Tomasz Wietecha, Kelly L Hudkins, et al.
Therapeutic Advances in Neurological Disorders
|
May 31, 2018
Phase IV study of retention on fingolimod <i>versus</i> injectable multiple sclerosis therapies: a randomized clinical trial
Bruce A C Cree, Douglas L Arnold, Mark Cascione, et al.
Nature Methods
|
April 8, 2015
Sequencing small genomic targets with high efficiency and extreme accuracy
Michael W Schmitt, Edward J Fox, Marc J Prindle, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
November 13, 2018
Ocrelizumab reduces progression of upper extremity impairment in patients with primary progressive multiple sclerosis: Findings from the phase III randomized ORATORIO trial
Edward J Fox, Clyde Markowitz, Angela Applebee, et al.
Biorxiv : the Preprint Server for Biology
|
July 15, 2025
Multiplex Proteomics of Lewy Body Dementia Reveals Cerebrospinal Fluid Biomarkers of Disease Pathology and Progression
Lenora Higginbotham, Anantharaman Shantaraman, Qi Guo, et al.
Page
of 13